| Literature DB >> 28753421 |
Azucena Ramos1, Michael T Hemann2.
Abstract
The tumor microenvironment has recently been shown to play decisive roles in chemotherapeutic response. In this issue of Cell, Yu et al. add to these findings by identifying the bacterium Fusobacterium nucleatum as a previously unrecognized chemoresistance mediator in colorectal cancer, thereby establishing the microbiota as a potential therapeutic target.Entities:
Mesh：
Year: 2017 PMID： 28753421 DOI： 10.1016/j.cell.2017.07.018
Source DB: PubMed Journal: Cell ISSN： 0092-8674 Impact factor: 41.582